Arpan Mohanty MBBS
Assistant Professor, Gastroenterology
85 E. Concord St | (617) 638-3019amohanty@bu.edu
Sections
Gastroenterology
Biography
Arpan Mohanty, MD, MSc is a hepatologist and clinical researcher at Boston Medical Center and Assistant Professor of Medicine Boston University Chobanian & Avedisian School of Medicine. Dr. Mohanty serves as the Director of Clinical Research in the Section of Gastroenterology
Dr. Mohanty’s research focuses on optimizing health-care delivery for advanced chronic liver disease and fatty liver disease. Her work has been supported by the National Institute on Minority Health and Health Disparities, the American Association for the Study of Liver Diseases, and the Radiological Society of North America, and she is the current recipient of the Robert Winn Career Development Award that focuses on community-oriented clinical trialists. She also serves as the principal investigator for several trials on chronic liver diseases. She is an active member of the American Association of Study of Liver Diseases and serves in its practice guidelines committee and fundamentals of liver disease committee.
Dr. Mohanty earned her medical degree in India, completed her internal medicine residency at the University of Pittsburgh Medical Center, gastroenterology fellowship at Yale New Haven Hospital, and advanced hepatology fellowship at Massachusetts General Hospital. She also holds a Master’s in Population Health from the Boston University School of Public Health. She is board certified in Internal Medicine, Gastroenterology, Transplant Hepatology and Obesity Medicine.
Education
MBBS, Rajiv Gandhi University of Health Sciences
Publications
Mohanty A, Stead AE, Telep LE, Singer AW, Curteis T, Zolotor A, Frenette C, Khoshabafard D, Hammond K, McQuaid T, Kelley RK. Hepatocellular carcinoma risk reduction associated with antiviral treatment in patients with noncirrhotic chronic hepatitis B: a systematic literature review and comparative meta-analysis. BMC Gastroenterol. 2026 Jun 26. PMID: 42363070.
Published on 4/22/2026Sharpton S, Díaz LA, Pepin K, Amangurbanova M, Madamba E, Bettencourt R, Singh S, Valasek M, Dalupang M, Tesfai K, Middleton MS, Behling C, Dunn W, Nakajima A, Imajo K, Ogawa Y, Caussy C, Halegoua-DeMarzio D, Mohanty A, Huang DQ, Fuchs M, Hameed B, Stine JG, Balakrishnan M, Gray M, Rodriguez M, DeLeon A, Puskoor R, Vuppalanchi R, Behari J, Hansen L, Miller C, Medici V, Sarkar S, Boursier J, Tincopa M, Ajmera V, Richards L, Sirlin CB, Ehman RL, Loomba R. Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes. Aliment Pharmacol Ther. 2026 Apr 22. PMID: 42017265.
Published on 4/17/2026Campos A, Liu T, Prescott B, Ma J, Haff MG, Walker ME, Mohanty A, Xanthakis V. Association of Life's Essential 8 with Hepatic Fibrosis, MASLD, and MetALD in the Framingham Heart Study. Nutrients. 2026 Apr 17; 18(8). PMID: 42075086.
Published on 12/29/2025Austad K, Fantasia KL, Mohanty A, Jones KC, Bosch NA, Drainoni ML. Failing to succeed: advancing mechanistic understanding of implementation strategies through retrospective and prospective use of causal pathway diagrams. Implement Sci Commun. 2025 Dec 29; 7(1):35. PMID: 41462368.
Published on 9/23/2025Austad K, Fantasia KL, Mohanty A, Jones KC, Bosch NA, Drainoni ML. Failing to Succeed: Advancing Mechanistic Understanding of Implementation Strategies Through Retrospective and Prospective Use of Causal Pathway Diagrams. Res Sq. 2025 Sep 23. PMID: 41041569.
Published on 8/16/2025Ghusn W, Gala K, Mrad R, Salame M, Rahme SJ, Santiago HR, Mohanty A, Chiu L, Hashash JG, Chedid V. Disparities in the burden of gastrointestinal diseases: a comprehensive analysis of data from randomized clinical trials from 2000-2023. Ann Gastroenterol. 2025; 38(5):488-496. PMID: 40937058.
Published on 8/13/2025Mohanty A, Wang Y, Stoecker C. Screening for MASLD and Advanced Fibrosis Among Patients With Obesity: A Cost-Effectiveness Analysis. Obesity (Silver Spring). 2025 Oct; 33(10):1845-1848. PMID: 40879614.
Published on 4/25/2025Mohanty A, Austad K, Bosch NA, Long MT, Nolen-Doerr E, Walkey AJ, Drainoni ML, Rizo I, Fantasia KL. Assessing Clinician Engagement With a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic. Endocr Pract. 2025 Jul; 31(7):899-905. PMID: 40288606.
Published on 12/14/2024Wong YJ, Buckholz A, Sim A, Teng M, Wong R, Curry MP, De Roza MA, Baffy G, Teoh X, Chak E, Rustagi T, Chang J, Wong GW, Tandon P, Garcia-Tsao G, Abraldes JG, Mohanty A, Fortune B. Nonalcohol-related Cirrhosis Leads to Higher 6-week Mortality After Acute Variceal Bleeding Than Alcohol-related Cirrhosis. Clin Gastroenterol Hepatol. 2025 Sep; 23(10):1776-1785.e10. PMID: 39675401.
Published on 7/20/2024Kumar S, Mohanty A, Mantry P, Schwartz RE, Haff M, Therapondos G, Noureddin M, Dieterich D, Girgrah N, Cohn K, Savanth M, Fuchs M. Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems. BMC Prim Care. 2024 Jul 20; 25(1):265. PMID: 39033284.